메뉴 건너뛰기




Volumn 6, Issue 3, 2008, Pages 281-289

Pegylated IFN-α2b plus ribavirin for treatment-naive patients coinfected with HCV and HIV

Author keywords

Antiviral agent; Chronic hepatitis C; Early virological response; HIV infection; HIV HCV coinfection; IFN 2b; Improved adherence; Negative predictive value; Positive predictive value; Rapid virological response; Relapse rate; Ribavirin; Sustained virological response; Viral load; Weight based

Indexed keywords

ABACAVIR; CYTOCHROME P450; DIDANOSINE; DRUG METABOLIZING ENZYME; FLECAINIDE; INTERFERON; NUCLEOSIDE ANALOG; PEGINTERFERON ALPHA2B; PHENYTOIN; RIBAVIRIN; WARFARIN; ZIDOVUDINE; ALPHA2B INTERFERON; ANTIVIRUS AGENT; PEGINTERFERON ALFA-2B;

EID: 48449104995     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.6.3.281     Document Type: Article
Times cited : (6)

References (51)
  • 1
    • 35348936097 scopus 로고    scopus 로고
    • Highlights of the third international workshop on HIV and hepatitis coinfection
    • Vogel M, Rockstroh J. Highlights of the third international workshop on HIV and hepatitis coinfection. Expert Rev. Anti Infect. Ther. 5(5), 769-771 (2007).
    • (2007) Expert Rev. Anti Infect. Ther , vol.5 , Issue.5 , pp. 769-771
    • Vogel, M.1    Rockstroh, J.2
  • 3
    • 30144437514 scopus 로고    scopus 로고
    • Epidemiology of viral hepatitis and HIV co-infection
    • Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J. Hepatol. 44(1 Suppl.), S6-S9 (2006).
    • (2006) J. Hepatol , vol.44 , Issue.1 SUPPL.
    • Alter, M.J.1
  • 4
    • 20044369545 scopus 로고    scopus 로고
    • Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection]
    • Laguno M, Sanchez-Tapias JM, Murillas J et al. [Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection]. Enferm. Infecc. Microbiol. Clin. 23(1), 32-40 (2005).
    • (2005) Enferm. Infecc. Microbiol. Clin , vol.23 , Issue.1 , pp. 32-40
    • Laguno, M.1    Sanchez-Tapias, J.M.2    Murillas, J.3
  • 5
    • 30144436182 scopus 로고    scopus 로고
    • Influence of HIV co-infection on hepatitis C immunopathogenesis
    • Koziel MJ. Influence of HIV co-infection on hepatitis C immunopathogenesis. J. Hepatol. 44(1 Suppl.), S14-S18 (2006).
    • (2006) J. Hepatol , vol.44 , Issue.1 SUPPL.
    • Koziel, M.J.1
  • 6
    • 20144389653 scopus 로고    scopus 로고
    • Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients
    • Alberti A, Clumeck N, Collins S et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J. Hepatol. 42(5), 615-624 (2005).
    • (2005) J. Hepatol , vol.42 , Issue.5 , pp. 615-624
    • Alberti, A.1    Clumeck, N.2    Collins, S.3
  • 7
    • 30144439971 scopus 로고    scopus 로고
    • Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection
    • Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J. Hepatol. 44(1 Suppl.), S28-34 (2006).
    • (2006) J. Hepatol , vol.44 , Issue.1 SUPPL.
    • Vallet-Pichard, A.1    Pol, S.2
  • 9
    • 33745217423 scopus 로고    scopus 로고
    • 2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus
    • 2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus. J. Viral Hepat. 13(7), 466-473 (2006).
    • (2006) J. Viral Hepat , vol.13 , Issue.7 , pp. 466-473
    • Moreno, A.1    Barcena, R.2    Garcia-Garzon, S.3
  • 12
    • 33947366502 scopus 로고    scopus 로고
    • 2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    • 2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients. J. Viral Hepat. 14(4), 228-238 (2006).
    • (2006) J. Viral Hepat , vol.14 , Issue.4 , pp. 228-238
    • Crespo, M.1    Sauleda, S.2    Esteban, J.I.3
  • 13
    • 0033054813 scopus 로고    scopus 로고
    • EASL international consensus conference on hepatitis C. Paris, 26-28, February 1999, consensus statement. European Association for the Study of the Liver. J. Hepatol. 30(5), 956-961 (1999).
    • EASL international consensus conference on hepatitis C. Paris, 26-28, February 1999, consensus statement. European Association for the Study of the Liver. J. Hepatol. 30(5), 956-961 (1999).
  • 14
    • 2442683905 scopus 로고    scopus 로고
    • 2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3
    • 2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J. Hepatol. 40(6), 993-999 (2004).
    • (2004) J. Hepatol , vol.40 , Issue.6 , pp. 993-999
    • Zeuzem, S.1    Hultcrantz, R.2    Bourliere, M.3
  • 15
    • 4444270265 scopus 로고    scopus 로고
    • 2b plus ribavirin for treatment of HIV/HCV co-infected patients
    • 2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS 18(13), F27-F36 (2004).
    • (2004) AIDS , vol.18 , Issue.13
    • Laguno, M.1    Murillas, J.2    Blanco, J.L.3
  • 16
    • 0035934568 scopus 로고    scopus 로고
    • 2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
    • 2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358(9286), 958-965 (2001).
    • (2001) Lancet , vol.358 , Issue.9286 , pp. 958-965
    • Manns, M.P.1    McHutchison, J.G.2    Gordon, S.C.3
  • 17
    • 30144444473 scopus 로고    scopus 로고
    • Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management
    • Mauss S. Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management. J. Hepatol. 44(1 Suppl.), S114-S118 (2006).
    • (2006) J. Hepatol , vol.44 , Issue.1 SUPPL.
    • Mauss, S.1
  • 18
    • 30144444611 scopus 로고    scopus 로고
    • Options for treatment of hepatitis C in HIV-infected persons
    • Thomas DL. Options for treatment of hepatitis C in HIV-infected persons. J. Hepatol. 44(1 Suppl.), S40-S43 (2006).
    • (2006) J. Hepatol , vol.44 , Issue.1 SUPPL.
    • Thomas, D.L.1
  • 19
    • 55249123297 scopus 로고    scopus 로고
    • PegIntron®, package insert. Schering-Plough Corporation. NJ, USA, June 2007
    • PegIntron®, package insert. Schering-Plough Corporation. NJ, USA, June (2007).
  • 20
    • 55249111456 scopus 로고    scopus 로고
    • Rebetol®, package insert. Schering-Plough Corporation. NJ, USA, July 2007
    • Rebetol®, package insert. Schering-Plough Corporation. NJ, USA, July (2007).
  • 21
    • 23644443360 scopus 로고    scopus 로고
    • Grace MJ, Cutler DL, Bordens RW. Pegylated IFNs for chronic hepatitis C: an update. Expert Opin. Drug Deliv. 2(2), 219-226 (2005).
    • Grace MJ, Cutler DL, Bordens RW. Pegylated IFNs for chronic hepatitis C: an update. Expert Opin. Drug Deliv. 2(2), 219-226 (2005).
  • 22
    • 10644244360 scopus 로고    scopus 로고
    • Pegylating IFNs at His-34 improves the in vitro antiviral activity through the JAK/STAT pathway
    • Grace MJ, Cutler D. Pegylating IFNs at His-34 improves the in vitro antiviral activity through the JAK/STAT pathway. Antivir. Chem. Chemother. 15(6), 287-297 (2004).
    • (2004) Antivir. Chem. Chemother , vol.15 , Issue.6 , pp. 287-297
    • Grace, M.J.1    Cutler, D.2
  • 23
    • 0033429408 scopus 로고    scopus 로고
    • Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C
    • Thomas HC, Torok ME, Forton DM, Taylor-Robinson SD. Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C. J. Hepatol. 31(Suppl. 1), 152-159 (1999).
    • (1999) J. Hepatol , vol.31 , Issue.SUPPL. 1 , pp. 152-159
    • Thomas, H.C.1    Torok, M.E.2    Forton, D.M.3    Taylor-Robinson, S.D.4
  • 24
    • 20044385757 scopus 로고    scopus 로고
    • Site of pegylation and polyethylene glycol molecule size attenuate interferon-α antiviral and antiproliferative activities through the JAK/STAT signaling pathway
    • Grace MJ, Lee S, Bradshaw S et al. Site of pegylation and polyethylene glycol molecule size attenuate interferon-α antiviral and antiproliferative activities through the JAK/STAT signaling pathway. J. Biol. Chem. 280(8), 6327-6336 (2005).
    • (2005) J. Biol. Chem , vol.280 , Issue.8 , pp. 6327-6336
    • Grace, M.J.1    Lee, S.2    Bradshaw, S.3
  • 25
    • 18444405565 scopus 로고    scopus 로고
    • Pharmacokinetics of pegylated interferons: What is misleading?
    • Caliceti P. Pharmacokinetics of pegylated interferons: what is misleading? Dig. Liver Dis. 36(Suppl. 3), S334-S339 (2004).
    • (2004) Dig. Liver Dis , vol.36 , Issue.SUPPL. 3
    • Caliceti, P.1
  • 26
    • 0034324083 scopus 로고    scopus 로고
    • 2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group
    • 2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group. Clin. Pharmacol. Ther. 68(5), 556-567 (2000).
    • (2000) Clin. Pharmacol. Ther , vol.68 , Issue.5 , pp. 556-567
    • Glue, P.1    Fang, J.W.2    Rouzier-Panis, R.3
  • 27
    • 48349109857 scopus 로고    scopus 로고
    • Peginterferons for the treatment of chronic hepatitis C
    • Grace MJ, Bordens RW, Cutler DL. Peginterferons for the treatment of chronic hepatitis C. Hepatology Rev. 2, 3-9 (2005).
    • (2005) Hepatology Rev , vol.2 , pp. 3-9
    • Grace, M.J.1    Bordens, R.W.2    Cutler, D.L.3
  • 30
    • 0032949443 scopus 로고    scopus 로고
    • The clinical pharmacology of ribavirin
    • Glue P. The clinical pharmacology of ribavirin. Semin. Liver Dis. 19 (Suppl, 1), 17-24 (1999).
    • (1999) Semin. Liver Dis , vol.19 , Issue.SUPPL.and 1 , pp. 17-24
    • Glue, P.1
  • 31
    • 0346098340 scopus 로고    scopus 로고
    • Ribavirin pharmacokinetics in renal and liver transplant patients: Evidence that it depends on renal function
    • Kamar N, Chatelut E, Manolis E, Lafont T, Izopet J, Rostaing L. Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function. Am. J. Kidney Dis. 43(1), 140-146 (2004).
    • (2004) Am. J. Kidney Dis , vol.43 , Issue.1 , pp. 140-146
    • Kamar, N.1    Chatelut, E.2    Manolis, E.3    Lafont, T.4    Izopet, J.5    Rostaing, L.6
  • 32
    • 0033844251 scopus 로고    scopus 로고
    • 2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group
    • 2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group. Hepatology 32(3), 647-653 (2000).
    • (2000) Hepatology , vol.32 , Issue.3 , pp. 647-653
    • Glue, P.1    Rouzier-Panis, R.2    Raffanel, C.3
  • 33
    • 10344230440 scopus 로고    scopus 로고
    • 2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial
    • 2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292(23), 2839-2848(2004).
    • (2004) JAMA , vol.292 , Issue.23 , pp. 2839-2848
    • Carrat, F.1    Bani-Sadr, F.2    Pol, S.3
  • 34
    • 2942696419 scopus 로고    scopus 로고
    • Viral factors affecting the outcome of therapy for chronic hepatitis C
    • Fried MW. Viral factors affecting the outcome of therapy for chronic hepatitis C. Rev. Gastroenterol. Disord. 4(Suppl. 1), S8-S13 (2004).
    • (2004) Rev. Gastroenterol. Disord , vol.4 , Issue.SUPPL. 1
    • Fried, M.W.1
  • 35
    • 30144435322 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis C in HIV-positive individuals: Selection of candidates
    • Soriano V. Treatment of chronic hepatitis C in HIV-positive individuals: selection of candidates. J. Hepatol. 44(1 Suppl.), S44-S48 (2006).
    • (2006) J. Hepatol , vol.44 , Issue.1 SUPPL.
    • Soriano, V.1
  • 36
    • 33845430865 scopus 로고    scopus 로고
    • Hepatic histologic response (HR) to combination therapy among HCV/HIV-coinfected individuals: Interferon induces HR independent of sustained virologic response (SVR)
    • Wu L, Kottilil S, Lempicki R et al. Hepatic histologic response (HR) to combination therapy among HCV/HIV-coinfected individuals: interferon induces HR independent of sustained virologic response (SVR). AIDS Res. Hum. Retroviruses 22(11), 1091-1098 (2006).
    • (2006) AIDS Res. Hum. Retroviruses , vol.22 , Issue.11 , pp. 1091-1098
    • Wu, L.1    Kottilil, S.2    Lempicki, R.3
  • 37
    • 15744381704 scopus 로고    scopus 로고
    • Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
    • Romero-Gomez M, Del Mar Viloria M, Andrade RJ et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128(3), 636-641 (2005).
    • (2005) Gastroenterology , vol.128 , Issue.3 , pp. 636-641
    • Romero-Gomez, M.1    Del Mar Viloria, M.2    Andrade, R.J.3
  • 38
    • 0035393683 scopus 로고    scopus 로고
    • Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy
    • Duong M, Petit JM, Piroth L et al. Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 27(3), 245-250 (2001).
    • (2001) J. Acquir. Immune Defic. Syndr , vol.27 , Issue.3 , pp. 245-250
    • Duong, M.1    Petit, J.M.2    Piroth, L.3
  • 39
    • 36349022057 scopus 로고    scopus 로고
    • 2b in African Americans with hepatitis C virus genotype 1
    • 2b in African Americans with hepatitis C virus genotype 1. Hepatology 46(4), 982-990 (2007).
    • (2007) Hepatology , vol.46 , Issue.4 , pp. 982-990
    • Jacobson, I.M.1    Brown Jr, R.S.2    McCone, J.3
  • 40
    • 36348974683 scopus 로고    scopus 로고
    • True' weight-based dosing versus 'flat' dosing of ribavirin: Will the WIN-R please come forward?
    • Smith J, Han SH. 'True' weight-based dosing versus 'flat' dosing of ribavirin: will the WIN-R please come forward? Hepatology 46(4), 953-956 (2007).
    • (2007) Hepatology , vol.46 , Issue.4 , pp. 953-956
    • Smith, J.1    Han, S.H.2
  • 41
    • 11244327853 scopus 로고    scopus 로고
    • Management of hepatitis C
    • Teo M, Hayes P. Management of hepatitis C. Br. Med. Bull. 70, 51-69 (2004).
    • (2004) Br. Med. Bull , vol.70 , pp. 51-69
    • Teo, M.1    Hayes, P.2
  • 42
    • 0038555663 scopus 로고    scopus 로고
    • 2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
    • 2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 17(7), 1023-1028 (2003).
    • (2003) AIDS , vol.17 , Issue.7 , pp. 1023-1028
    • Perez-Olmeda, M.1    Nunez, M.2    Romero, M.3
  • 43
    • 30144443736 scopus 로고    scopus 로고
    • Treatment algorithm for the management of hepatitis C in HIV-coinfected persons
    • Sulkowski MS. Treatment algorithm for the management of hepatitis C in HIV-coinfected persons. J. Hepatol. 44(1 Suppl.), S49-S55 (2006).
    • (2006) J. Hepatol , vol.44 , Issue.1 SUPPL.
    • Sulkowski, M.S.1
  • 44
    • 34247624140 scopus 로고    scopus 로고
    • Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: Does abacavir play a role?
    • Bani-Sadr F, Denoeud L, Morand P, et al. Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role? J. Acquir. Immune Defic. Syndr. 45, 123-125 (2007).
    • (2007) J. Acquir. Immune Defic. Syndr , vol.45 , pp. 123-125
    • Bani-Sadr, F.1    Denoeud, L.2    Morand, P.3
  • 45
    • 33745501500 scopus 로고    scopus 로고
    • 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients
    • 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients. J. Infict. 53(1), 36-42 (2006).
    • (2006) J. Infict , vol.53 , Issue.1 , pp. 36-42
    • Voigt, E.1    Schulz, C.2    Klausen, G.3
  • 46
    • 21844477798 scopus 로고    scopus 로고
    • Open, randomized, multicentre italian trial on PEG-IFN-plus ribavirin versus PEG-IFN-monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART
    • Cargnel A, Angeli E, Mainini A et al. Open, randomized, multicentre italian trial on PEG-IFN-plus ribavirin versus PEG-IFN-monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART. Antivir. Ther. 10(2), 309-317 (2005).
    • (2005) Antivir. Ther , vol.10 , Issue.2 , pp. 309-317
    • Cargnel, A.1    Angeli, E.2    Mainini, A.3
  • 47
    • 33646163653 scopus 로고    scopus 로고
    • 2b Plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    • 2b Plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. AIDS Res. Hum. Retroviruses 22(4), 315-320 (2006).
    • (2006) AIDS Res. Hum. Retroviruses , vol.22 , Issue.4 , pp. 315-320
    • Santin, M.1    Shaw, E.2    Garcia, M.J.3
  • 48
    • 1642546905 scopus 로고    scopus 로고
    • 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    • 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. AIDS 18(1), 67-73 (2004).
    • (2004) AIDS , vol.18 , Issue.1 , pp. 67-73
    • Moreno, L.1    Quereda, C.2    Moreno, A.3
  • 49
    • 12144289459 scopus 로고    scopus 로고
    • Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: Indications for the investigation of new treatment approaches
    • Ballesteros AL, Franco S, Fuster D et al. Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: indications for the investigation of new treatment approaches. AIDS 18(1), 59-66 (2004).
    • (2004) AIDS , vol.18 , Issue.1 , pp. 59-66
    • Ballesteros, A.L.1    Franco, S.2    Fuster, D.3
  • 51
    • 36949015153 scopus 로고    scopus 로고
    • Old and emerging therapies in chronic hepatitis C: An update
    • Deutsch M, Hadziyannis SJ. Old and emerging therapies in chronic hepatitis C: an update. J. Viral Hepat. 15(1), 2-11 (2008).
    • (2008) J. Viral Hepat , vol.15 , Issue.1 , pp. 2-11
    • Deutsch, M.1    Hadziyannis, S.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.